JOHNSON & JOHNSON — Director's Dealing 2017

Mar 2, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2017-02-28

Reporting Person: Pruden Gary J (Exec VP, WW Chair, Med Devices)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-28	Common Stock	S	16299.0000	$122.2126	Disposed	43630.4236	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	96.0000	Indirect

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $122.16 to $122.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.